Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-12
2010-10-26
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07820686
ABSTRACT:
The invention is directed to a method of treating an inflammatory bowel disease such as ulcerative colitis or Crohn's disease, which comprises administering an effective amount of the therapeutic agent 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione, or a pharmaceutically acceptable salt thereof, to a patient with inflammatory bowel disease.
REFERENCES:
patent: 5744475 (1998-04-01), Yano et al.
patent: 6479500 (2002-11-01), Fukushima et al.
patent: 2001/0016214 (2001-08-01), Kanauchi et al.
patent: 1 080 726 (2001-03-01), None
patent: 96 30346 (1996-10-01), None
patent: 97 37674 (1997-10-01), None
patent: 98 13045 (1998-04-01), None
patent: 2000 56337 (2000-09-01), None
Zou et al., Journal of Tongji Medical University, 21(4), (2001), pp. 308-309.
Stephan R. Targan, et al., “A short-term study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease”, The New England Journal of Medicine, Oct. 9, 1997, vol. 337, No. 15, pp. 1029-1035.
Paul Rutgeerts, et al., “Efficacy and Safety of Retreatment With Anti-Tumor Necrosis Factor Antibody (Infliximab) to Maintain Remission in Crohn's Disease”, Gastroenterology, 1999, vol. 117, No. 4, pp. 761-769.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Spivack Phyllis G.
Taiho Pharmaceutical Co. Ltd.
LandOfFree
Therapeutic agent for inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for inflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177221